ADO 4.35% 2.2¢ anteotech ltd

Ann: Study Confirms Targeted Sensitivity of COVID-19 Test, page-10

  1. 2,662 Posts.
    lightbulb Created with Sketch. 160


    Is Derek Thompson indicating the Operon/ADO test won't produce false negatives? or to say it another way , they are hoping to develop a test which is 100% accurate with 15 minute results?


    AnteoTech’s CEO Derek Thomson commented:“We are very pleased to have reached this key milestone in our development of the AnteoTech COVID-19 Antigen Rapid Test. The control of COVID-19 requires highly sensitive testing to ensure all positive patients are identified and isolated at the point of care to ensure they don’t continue to spread the disease. We believe we are making an important contribution to the control of the disease and we look forward to entering clinical trials following the final stages of our validation phase which we believe will lead to making our test available to global markets very soon.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
-0.001(4.35%)
Mkt cap ! $56.77M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $173 7.842K

Buyers (Bids)

No. Vol. Price($)
3 917211 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 680817 4
View Market Depth
Last trade - 13.00pm 05/09/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.